6 months ago
Biomarkers Industry Data Book - Cardiac Biomarkers, Cancer Biomarkers, Non-alcoholic Steatohepatitis Biomarkers, Neurological Biomarkers Market
Download Sample Copy@ https://tinyurl.com/3r28tf...
The global biomarkers markets combine to account for USD 41.62 billion revenue in 2021, which is expected to reach USD 137.76 billion by 2030, growing at a cumulative rate of 14.2% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.
The global cardiac biomarkers market was valued at USD 13.98 billion in 2021 and is anticipated to witness growth at a rate of 14.7% over the forecast period. CVDs are one of the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. Identifying early-stage biomarkers of hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases. In addition, new research is focused on discovering second-generation biomarkers for CVDs. Constant advancements in this field to discover novel biomarkers are anticipated to boost segment growth.
#BiomarkersIndustry #FutureOfBiomarkers #BiotechInnovation #PrecisionMedicine #DiagnosticAdvancements #HealthcareTechnology #PersonalizedMedicine #BiomarkerResearch #MedicalBreakthroughs #DiseaseDetection
Download Sample Copy@ https://tinyurl.com/3r28tf...
The global biomarkers markets combine to account for USD 41.62 billion revenue in 2021, which is expected to reach USD 137.76 billion by 2030, growing at a cumulative rate of 14.2% over the forecast period. The combination bundle is designed to provide a holistic view of these highly dynamic market spaces.
The global cardiac biomarkers market was valued at USD 13.98 billion in 2021 and is anticipated to witness growth at a rate of 14.7% over the forecast period. CVDs are one of the main causes of death globally, and hypertension & its pathological adverse effects pose a significant risk for other cardiac diseases, such as heart failure & stroke. Identifying early-stage biomarkers of hypertension and other CVDs is of high significance in predicting & preventing major mortality & morbidity related to these diseases. In addition, new research is focused on discovering second-generation biomarkers for CVDs. Constant advancements in this field to discover novel biomarkers are anticipated to boost segment growth.
#BiomarkersIndustry #FutureOfBiomarkers #BiotechInnovation #PrecisionMedicine #DiagnosticAdvancements #HealthcareTechnology #PersonalizedMedicine #BiomarkerResearch #MedicalBreakthroughs #DiseaseDetection
